Plan for Testing Fingerstick Bloods on Magellan Systems
Plan for Testing Fingerstick Bloods on Magellan Systems
This study is to supplement our internal data that demonstrates the continued performance of
 capillary blood samples on Magellan's lead testing systems: LeadCare II, LeadCare Ultra
 (which have been cleared previously by FDA), and PediaStat, which is an upgraded LeadCare II
 instrument in development.
Inclusion Criteria:

 -  healthy subjects who consent to a capillary blood collection

 Exclusion Criteria:

 -  Patients are not currently taking chelating agents, e.g., penicillamine, succimer